Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucuronidation of N-acetylbenzidine by human liver

S R Babu1, V M Lakshmi, T V Zenser

  • 1Veterans Administration Medical Center, St. Louis, MO 63125-4199.

Drug Metabolism and Disposition: the Biological Fate of Chemicals
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pancreatic Castleman's Disease: Studies of Three Cases And A Cumulative Review of the Literature.

The Indian journal of surgery·2014
Same author

Differential effects of DRB1*0301 and DQA1*0501-DQB1*0201 on the activation and progression of islet cell autoimmunity.

Genes and immunity·2007
Same author

Outcomes of coronary artery bypass grafting: a 3 year analysis using the Society of Thoracic Surgeons Database.

Heart, lung & circulation·2005
Same author

Clinical-pathologic conference in general thoracic surgery: Disseminated nocardiosis presenting as Pancoast syndrome.

The Journal of thoracic and cardiovascular surgery·2004
Same author

Autoimmune myasthenia gravis: place of thymectomy and preferred technique.

Internal medicine journal·2003
Same author

Reactive nitrogen oxygen species metabolize N-acetylbenzidine.

Chemical research in toxicology·2001
Same journal

Reduction of secondary 3-keto bile acids by aldo-keto reductase 1C1 and 1C4.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Construction of a curated human pharmacokinetics database for molecular fragment analysis and machine learning applications.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Finding the dispersion number (D<sub>N</sub>) of the dispersion model from perfused rat and human liver studies.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Role of organic anion transporting polypeptides in pancreatic statin disposition and islet cell function in mice.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

The regulatory potential of cytochrome P450-adrenodoxin interactions: Insights toward understanding redox partner regulation in drug metabolizing enzymes.

Drug metabolism and disposition: the biological fate of chemicals·2026
See all related articles

N-Glucuronidation is a major metabolic pathway for N-acetylbenzidine in humans, involving multiple UDP-glucuronosyltransferases. This study characterized the kinetics and identified key inhibitors of this process.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Toxicology

Background:

  • N-Glucuronidation is a critical metabolic route for aromatic amines.
  • Understanding N-acetylbenzidine metabolism is vital for assessing its toxicological profile.

Purpose of the Study:

  • To investigate the N-glucuronidation of N-acetylbenzidine in human liver.
  • To characterize the kinetics of N-acetylbenzidine N'-glucuronide formation.
  • To identify the UDP-glucuronosyltransferases involved in this metabolism.

Main Methods:

  • Incubation of [3H]N-acetylbenzidine with human liver slices and microsomes.
  • High-performance liquid chromatography (HPLC) for metabolite separation and quantification.
  • Enzyme kinetic analysis (Michaelis-Menten model) and inhibition studies using known UDP-glucuronosyltransferase substrates.

Related Experiment Videos

Main Results:

  • N-acetylbenzidine N'-glucuronide was a significant metabolite in human liver samples.
  • Enzyme kinetics followed a two-component Michaelis-Menten model, indicating high- and low-affinity UDP-glucuronosyltransferases.
  • Estriol and 4-aminobiphenyl showed significant inhibition, suggesting involvement of specific UDP-glucuronosyltransferases.

Conclusions:

  • N-Glucuronidation is a major pathway for N-acetylbenzidine metabolism in humans.
  • Multiple UDP-glucuronosyltransferases likely contribute to N-acetylbenzidine metabolism.
  • Inhibition studies provide insights into the specific enzymes involved.